neg
falseneg
respect
preval
rel
frequenc
posit
class
ie
preval
p
p
n
unless
mention
otherwis
posit
neg
refer
patient
bacteri
viral
infect
respect
also
use
area
receiv
oper
curv
auc
perform
cutoff
independ
comparison
differ
diagnost
method
detail
formul
confid
interv
ci
comput
auc
see
hanley
mcneil
report
ci
accuraci
measur
throughout
document
primari
studi
object
obtain
perform
signatur
classifi
patient
viral
bacteri
etiolog
estim
sampl
size
requir
reject
null
hypothesi
sensit
entir
popul
p
lower
p
h
p
p
h
p
p
signific
level
power
differ
p
p
p
empir
sensit
yield
patient
viral
bacteri
addit
anticip
roughli
patient
indetermin
sourc
infect
would
exclud
technic
reason
healthi
noninfecti
control
taken
togeth
studi
requir
recruit
least
patient
requir
fulfil
patient
recruit
systemat
literatur
bioinformat
screen
appli
identifi
protein
candid
potenti
differenti
express
respons
infect
literatur
review
includ
collect
protein
known
role
immun
inflamm
human
anim
bioinformat
screen
includ
protein
differenti
express
rna
level
across
differ
infect
inflammatori
condit
measur
use
high
throughput
sequenc
techniqu
microarray
appli
featur
select
process
identifi
optim
combin
protein
use
two
featur
select
scheme
mutualinform
minmax
forward
greedi
wrapper
use
seri
iter
add
remov
featur
process
termin
increas
perform
train
set
longer
statist
signific
p
process
converg
final
set
three
protein
integr
protein
level
singl
score
examin
multipl
comput
model
perform
significantli
differ
p
supplementari
materi
chose
multinomi
logist
regress
mlr
model
provid
probabilist
interpret
assign
likelihood
score
patient
diagnosi
signatur
use
properti
flag
patient
whose
probabl
bacteri
infect
intermedi
use
term
margin
immun
respons
describ
patient
profil
border
bacteri
viral
hostrespons
integr
protein
level
singl
predict
score
examin
multipl
comput
model
includ
artifici
neural
network
ann
support
vector
machin
svm
bayesian
network
bn
knearest
neighbor
knn
multinomi
logist
regress
mlr
auc
distinguish
bacteri
viral
infect
obtain
entir
studi
cohort
use
cross
valid
observ
signific
differ
perform
ann
svm
mlr
model
p
compar
auc
therefor
chose
use
mlr
provid
probabilist
interpret
assign
likelihood
score
patient
diagnosi
train
test
mlr
signatur
distinguish
bacteri
viral
noninfecti
etiolog
sinc
preval
underli
etiolog
vari
across
differ
clinic
set
model
prior
adjust
reflect
nonbacteri
preval
bacteri
preval
within
nonbacteri
group
prior
adjust
viral
noninfecti
reflect
anticip
higher
preval
viral
versu
noninfecti
patient
among
subject
suspici
acut
infect
mlr
weight
respect
confid
interv
well
pvalu
associ
coeffici
summar
tabl
bacteri
versu
viral
infect
analysi
probabl
adjust
sum
p
badjust
p
b
p
b
p
v
p
badjust
p
v
p
b
p
v
p
b
p
v
correspond
probabl
bacteri
viral
infect
respect
order
assess
valid
mlr
model
compar
estim
predict
probabl
actual
observ
outcom
fig
predict
probabl
highli
compat
observ
one
demonstr
model
valid
nonlinear
mlr
model
potenti
captur
subtl
trend
data
compar
linear
model
retain
probabilist
framework
allow
meaning
interpret
model
result
examin
multipl
nonlinear
mlr
model
appli
featur
select
process
identifi
optim
featur
combin
section
result
model
depict
tabl
signatur
perform
examin
studi
cohort
exclud
follow
two
subgroup
patient
whose
blood
sampl
taken
day
antibiot
treatment
hospit
ii
patient
suspect
gastroenter
first
group
like
includ
patient
convalesc
respond
treatment
therefor
immun
respons
time
sampl
alreadi
nonbacteri
second
group
show
slightli
reduc
perform
tabl
